Publication | Closed Access

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Topical NitroglycerinMedicinePhase IiiPharmacologyClinical TrialsMetronomic TherapyPharmacotherapyCancer TreatmentLung CancerFirst-line ChemotherapyOncologyCancer ChemotherapyChemotherapyCancer Research